Algeta US Celebrates Official Opening of Operational Center in Cambridge, MA

20-Sep-2012 - USA

Algeta ASA celebrated the official opening of the offices and facilities of Algeta US in Cambridge, Massachusetts.

In September 2009, Algeta signed an agreement with Bayer for the development and commercialization of Alpharadin. Under the terms of the agreement, Bayer will develop, apply for global health authority approvals and commercialize Alpharadin globally, and Algeta will co-promote it with Bayer in the US.

“Algeta Group’s expansion to the US is an important step toward realizing our vision for building a global oncology company commercializing innovation. We have brought on experienced sales, marketing and medical affairs executives to build our US commercial operation and plan to deliver a phased build-up of resources in anticipation of a US commercial launch, with Bayer, of Alpharadin if approved by FDA. We look forward to contributing to the commercial success of the Massachusetts biotech economy and joining the region’s growing group of commercial-stage companies,” said Jeff Albers, President Algeta US.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances